Skip to main content
GutCited

Description

Primary efficacy outcome data from a randomized controlled trial showing the duration and severity of acute diarrhea episodes in children receiving Bacillus clausii probiotic supplementation alongside standard ORT and zinc therapy.

Cite This Figure

![Figure 2: Primary efficacy outcome data from a randomized controlled trial showing the duration and severity of acute diarrhea episodes in children receiving Bacillus clausii probiotic supplementation alongside standard ORT and zinc therapy.]()

> Source: Keya Rani Lahiri et al. "Efficacy and safety of Bacillus clausii (O/C, N/R, SIN, T) probiotic combined wi." *Tropical diseases, travel medicine and vaccines*, 2022. PMID: [35397572](https://pubmed.ncbi.nlm.nih.gov/35397572/)
<figure>
  <img src="" alt="Primary efficacy outcome data from a randomized controlled trial showing the duration and severity of acute diarrhea episodes in children receiving Bacillus clausii probiotic supplementation alongside standard ORT and zinc therapy." />
  <figcaption>Figure 2. Primary efficacy outcome data from a randomized controlled trial showing the duration and severity of acute diarrhea episodes in children receiving Bacillus clausii probiotic supplementation alongside standard ORT and zinc therapy.<br>  Source: Keya Rani Lahiri et al. "Efficacy and safety of Bacillus clausii (O/C, N/R, SIN, T) probiotic combined wi." <em>Tropical diseases, travel medicine and vaccines</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35397572/">35397572</a></figcaption>
</figure>